Dr. Andrew Gostine, CEO of\xa0Artisight,\xa0focused on\xa0the transformative potential of augmented intelligence in healthcare,\xa0speaks with\xa0Dr. Christine Stock, Managing Director of Medical Affairs at Health2047. Dr. Gostine highlights the development of bedside AI and its aim to enhance workflows, reduce nurse turnover, and improve efficiency by offloading specific tasks to AI\xa0so that those staff can perform direct patient care.\xa0They discuss the importance of AI evolving alongside clinicians and patients, envisioning its future impact on clinical decision support and transforming healthcare.